Announcements

Issuance And Allotment Of 1,185,000 New Ordinary Shares In The Capital Of The Company

REPL::Financial Statements and Related Announcement::Full Yearly Results

Financial Statements and Related Announcement::Full Yearly Results

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer

Issuance And Allotment Of 882,960 New Ordinary Shares In The Capital Of The Company

Execution of Non-Binding Letter of Intent with Amarantus BIoScience Holdings, Inc.

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer

Issuance And Allotment Of 5,794,900 New Ordinary Shares In The Capital Of The Company